Houlihan Lokey
Jordan Mendel serves as a Managing Director at Houlihan Lokey since May 2018, having previously held positions including Director, Senior Vice President, and Vice President on the Business Services team within Corporate Finance. Prior experience includes a role as Principal and Generalist Associate in Investment Banking at Centerview Partners, where significant advisory work included Pfizer Inc.'s $14 billion acquisition of Medivation, Inc. Jordan's earlier career featured positions at Citi in Mergers & Acquisitions, advising major transactions such as the sale of OCI Enterprises and Tecumseh Products Company. Academic credentials comprise an MBA from The University of Chicago Booth School of Business, a Master's in Chemical Engineering from Columbia Engineering, and a Bachelor of Science in Chemical Engineering from the University of Pennsylvania.
Previous companies
This person is not in any teams
This person is not in any offices
Houlihan Lokey
13 followers
Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and financial and valuation advisory. The firm serves corporations, institutions, and governments worldwide with offices in the Americas, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. Houlihan Lokey is the No. 1 investment bank for global M&A transactions under $1 billion, the No. 1 M&A advisor for the past eight consecutive years in the U.S., the No. 1 global restructuring advisor for the past nine consecutive years, and the No. 1 global M&A fairness opinion advisor over the past 25 years, all based on number of transactions and according to data provided by Refinitiv.